ES2072424T3 - Formula y metodo para el tratamiento de hipertrofias prostaticas benignas. - Google Patents
Formula y metodo para el tratamiento de hipertrofias prostaticas benignas.Info
- Publication number
- ES2072424T3 ES2072424T3 ES90902952T ES90902952T ES2072424T3 ES 2072424 T3 ES2072424 T3 ES 2072424T3 ES 90902952 T ES90902952 T ES 90902952T ES 90902952 T ES90902952 T ES 90902952T ES 2072424 T3 ES2072424 T3 ES 2072424T3
- Authority
- ES
- Spain
- Prior art keywords
- benign prostatic
- composition
- preferably comprises
- hypertrophies
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA INVENCION SE REFIERE A UNA COMPOSICION Y UN METODO PARA TRATAR LA HIPERTROFIA PROSTATICA BENIGNA EN LOS MAMIFEROS DE MANERA QUE SE PROVOQUE LA DISOLUCION Y LA REGRESION DEL TEJIDO PROSTATICO HIPERTROFIADO CON LO QUE SE ALIVIA LOS SINTOMAS DE OBSTRUCCION ASOCIADOS A LA ENFERMEDAD. LA PRESENTE COMPOSICION COMPRENDE PREFERENTEMENTE UNA SOLUCION LIBRE DE PIROGENO ESTERIL DE LA COLAGENASA DE ENZIMAS HIDROLITICAS E HIALURONIDASA , UN SURFACTANTE NO IONICO, Y UN ANTIBIOTICO; TODO PREVISTO EN UN PORTADOR ACUOSO ISOTOMICO, TAMPONADO, FARMACEUTICAMENTE ACEPTABLE. EL PRESENTE METODO COMPRENDE PREFERENTEMENTE LA INYECCION INTRAPROSTATICA DIRECTA DE UNA DOSIS TERAPEUTICAMENTE EFECTIVA Y SEGURA DE LA COMPOSICION POR VIA DE ADMINISTRACION TRANSURETRAL.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30380989A | 1989-01-27 | 1989-01-27 | |
US42996689A | 1989-10-31 | 1989-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2072424T3 true ES2072424T3 (es) | 1995-07-16 |
Family
ID=26973659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES90902952T Expired - Lifetime ES2072424T3 (es) | 1989-01-27 | 1990-01-19 | Formula y metodo para el tratamiento de hipertrofias prostaticas benignas. |
Country Status (10)
Country | Link |
---|---|
US (1) | US6296847B1 (es) |
EP (1) | EP0456724B1 (es) |
JP (1) | JP3054190B2 (es) |
AT (1) | ATE121946T1 (es) |
AU (1) | AU5045690A (es) |
DE (1) | DE69019141T2 (es) |
DK (1) | DK0456724T3 (es) |
ES (1) | ES2072424T3 (es) |
HK (1) | HK1003981A1 (es) |
WO (1) | WO1990008555A1 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4305460C2 (de) * | 1993-02-23 | 1997-09-04 | Albert Dr Scheller | Pharmazeutische oder kosmetische, Enzyme enthaltende Zubereitung, Verfahren zu deren Herstellung und deren Verwendung |
US7018365B2 (en) | 1999-05-21 | 2006-03-28 | Micro Therapeutics, Inc. | Threaded syringe with quick stop |
US6022539A (en) * | 1999-06-03 | 2000-02-08 | Advance Biofactures Of Curacao | Amelioration of peyronie's disease |
US7063838B1 (en) | 1999-09-24 | 2006-06-20 | Proteon Therapeutics Llc | Methods for treating an artery or vein in a human subject |
EP2332568A1 (en) * | 1999-09-24 | 2011-06-15 | Proteon Therapeutics, Inc. | Collagenase for opening obstructed biological conduits |
US6428785B1 (en) * | 1999-10-28 | 2002-08-06 | Immunolytics Inc. | Method and composition for treating prostate cancer |
US6678391B2 (en) * | 2000-04-18 | 2004-01-13 | Matsushita Electric Industrial Co., Ltd. | Organism-specimen morphological-change detecting apparatus, and organism-specimen morphological-change detecting method |
WO2002074329A1 (en) * | 2001-03-19 | 2002-09-26 | Ribeiro Santana Cristiano Albe | Pharmaceutical composition applied to the treatment of the peyronie disease and corresponding obtention process |
WO2003066088A2 (de) * | 2002-02-06 | 2003-08-14 | Trommsdorff Gmbh & Co. Kg Arzneimittel | Protease-screening und neue verwendung von proteasen |
EP1521523A4 (en) * | 2002-05-20 | 2006-04-19 | Univ Texas | METHODS AND COMPOSITIONS FOR DELIVERING NUCLEIC ACID ENZYMES AND MOLECULES IN BRAIN, BONE, AND OTHER FABRICS |
US20060034824A1 (en) * | 2002-09-19 | 2006-02-16 | Santana Cristiano A R | Pharmaceutical composition comprising carriers for products |
US7437194B2 (en) * | 2003-10-31 | 2008-10-14 | Medtronic, Inc. | Stimulating the prostate gland |
MXPA03011987A (es) | 2003-12-19 | 2005-06-23 | Osio Sancho Alberto | Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal. |
US7572613B2 (en) * | 2004-06-25 | 2009-08-11 | Klein Jeffrey A | Drug delivery system for accelerated subcutaneous absorption |
JP4913074B2 (ja) | 2005-03-03 | 2012-04-11 | アラーガン、インコーポレイテッド | 動物由来産物不含方法およびボツリヌス毒素を精製するための方法 |
KR101447184B1 (ko) * | 2006-11-10 | 2014-10-08 | 엘아이지에이디피 주식회사 | 게이트슬릿 개폐장치가 구비된 공정챔버 |
WO2008101098A2 (en) | 2007-02-15 | 2008-08-21 | Allergan, Inc. | Use of botulinum toxin and enzymes for treating bladder or prostata disorders, or hyperhydrosis |
AT506095A1 (de) * | 2007-12-03 | 2009-06-15 | Volopharm Gmbh | Verwendung von proteasen |
US8449512B2 (en) | 2010-04-09 | 2013-05-28 | Davinci Biomedical Research Products Inc. | Stoma stabilitating device and method |
WO2012109387A1 (en) * | 2011-02-08 | 2012-08-16 | Halozyme, Inc. | Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia |
MX350145B (es) * | 2011-07-20 | 2017-08-28 | Mediwound Ltd | Extracto proteolitico a partir de bromelaina para el tratamiento de trastornos del tejido conectivo. |
US20130178454A1 (en) * | 2011-11-17 | 2013-07-11 | Shalender Bhasin | Combination of testosterone and ornithine decarboxylase (odc) inhibitors |
CN111290143B (zh) | 2012-08-10 | 2023-03-31 | 奥西奥公司以约利亚健康公司名义经营 | 隐形眼镜和为个体的眼睛测定隐形眼镜的适配的方法 |
US10835538B2 (en) * | 2018-03-28 | 2020-11-17 | Nymox Corporation | Method of treating benign prostatic hyperlasia with antibiotics |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE744162A (fr) | 1969-01-16 | 1970-06-15 | Fuji Photo Film Co Ltd | Procede d'encapsulage |
US3792161A (en) | 1970-05-18 | 1974-02-12 | Research Corp | Burn ointment comprising silver sulfadiazine and collagenase |
US3678158A (en) | 1971-05-11 | 1972-07-18 | Worthington Bio Chem Corp | Treatment of herniated intervertebral discs of mammals |
US4276284A (en) | 1971-07-26 | 1981-06-30 | Brown Stuart I | Prevention of collagenase induced disease by treatment with collagenase inhibitors |
US3977408A (en) | 1974-11-01 | 1976-08-31 | Mackew Allan H | Prosthetic catheter |
US4005194A (en) | 1975-06-23 | 1977-01-25 | Abbott Laboratories | Treatment of prostatic hyperplasia |
US4317818A (en) | 1976-05-10 | 1982-03-02 | Richardson-Merrell Inc. | Method of treating prostatic carcinoma |
DE2655801C2 (de) | 1976-12-09 | 1986-06-26 | Kernforschungsanlage Jülich GmbH, 5170 Jülich | Injizierbare Suspension von Membranvesikeln aus Erythrozyten und Verfahren zur Herstellung der Suspension |
US4174389A (en) | 1977-05-13 | 1979-11-13 | Cope Louise A | Ophthalmic use of collagenase |
CH624011A5 (es) | 1977-08-05 | 1981-07-15 | Battelle Memorial Institute | |
DE2817157A1 (de) | 1978-04-17 | 1979-10-25 | Schering Ag | Verwendung von antioestrogenen und antigonadotrop wirkenden antiandrogenen zur prophylaxe und therapie der prostatahyperplasie |
US4329430A (en) * | 1979-06-04 | 1982-05-11 | Klein Gerold K V | Enzyme mixture |
US4317817A (en) | 1979-08-27 | 1982-03-02 | Richardson-Merrell Inc. | Novel steroid 5α-reductase inhibitors |
US4276281A (en) | 1980-09-04 | 1981-06-30 | Crikelair George F | Burn treatment |
US4338300A (en) | 1981-02-05 | 1982-07-06 | The Regents Of The University Of California | Use of purified clostridial collangenase in the treatment of Peyronie's disease |
JPS5826822A (ja) | 1981-08-10 | 1983-02-17 | Kaken Pharmaceut Co Ltd | 慢性腎炎治療剤 |
JPS58189122A (ja) | 1982-04-30 | 1983-11-04 | Kaken Pharmaceut Co Ltd | 高脂血症予防治療剤 |
JPS5951221A (ja) | 1982-09-17 | 1984-03-24 | Eisai Co Ltd | 変形性関節症治療剤 |
IT1189379B (it) * | 1982-10-08 | 1988-02-04 | Serono Ist Farm | Composizione farmaceutica contenente un agente fibrinolitico ed un fattore di diffusione,utile per il trattamento dell'infarto miocardico |
US4524065A (en) * | 1983-08-04 | 1985-06-18 | Bio-Specifics N.V. | Method for the prevention and treatment of scars with enzymes |
US4645668A (en) * | 1983-08-04 | 1987-02-24 | Biospecifics, Nv | Method for the prevention and treatment of scars with enzymes |
US4659695A (en) * | 1985-02-08 | 1987-04-21 | Fernand Labrie | Method of treatment of prostate cancer |
US4678668A (en) * | 1985-10-28 | 1987-07-07 | Md Associates | Method of reducing soft tissue swelling and pain |
US5116615A (en) * | 1989-01-27 | 1992-05-26 | Immunolytics, Inc. | Method for treating benign prostatic hypertrophy |
-
1990
- 1990-01-19 AT AT90902952T patent/ATE121946T1/de not_active IP Right Cessation
- 1990-01-19 AU AU50456/90A patent/AU5045690A/en not_active Abandoned
- 1990-01-19 WO PCT/US1990/000423 patent/WO1990008555A1/en active IP Right Grant
- 1990-01-19 DK DK90902952.2T patent/DK0456724T3/da active
- 1990-01-19 DE DE69019141T patent/DE69019141T2/de not_active Expired - Fee Related
- 1990-01-19 JP JP2503414A patent/JP3054190B2/ja not_active Expired - Fee Related
- 1990-01-19 EP EP90902952A patent/EP0456724B1/en not_active Expired - Lifetime
- 1990-01-19 ES ES90902952T patent/ES2072424T3/es not_active Expired - Lifetime
-
1993
- 1993-11-17 US US08/154,158 patent/US6296847B1/en not_active Expired - Fee Related
-
1998
- 1998-04-17 HK HK98103224A patent/HK1003981A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69019141D1 (de) | 1995-06-08 |
JPH04503071A (ja) | 1992-06-04 |
DE69019141T2 (de) | 1996-01-18 |
ATE121946T1 (de) | 1995-05-15 |
EP0456724B1 (en) | 1995-05-03 |
HK1003981A1 (en) | 1998-11-13 |
US6296847B1 (en) | 2001-10-02 |
DK0456724T3 (da) | 1995-10-02 |
WO1990008555A1 (en) | 1990-08-09 |
JP3054190B2 (ja) | 2000-06-19 |
EP0456724A1 (en) | 1991-11-21 |
AU5045690A (en) | 1990-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2072424T3 (es) | Formula y metodo para el tratamiento de hipertrofias prostaticas benignas. | |
ES2170141T3 (es) | 4-aminoderivados del acido micofenolico con actividad inmunosupresora. | |
DE60036490D1 (de) | Zusammensetzung zur behandlung von prostatakrebs | |
DK1140078T3 (da) | Vaskulærskadende benzimidazolmidler | |
CO5011115A1 (es) | Compuestos y metodos quimioquina | |
ES2151192T3 (es) | Compuestos de quinolina y quinazolina utiles en terapia. | |
DE69534150D1 (de) | Präsynaptische Neurotoxine gegen Migränekopfschmerzen | |
TR199801151T2 (xx) | Trombin inhibit�r� �n ila�lar. | |
FI952607A (fi) | Farmakologisesti aktiiviset pyridiinijohdannaiset ja menetelmät niiden valmistamiseksi | |
AR039416A1 (es) | Un metodo para prevenir y/o tratar el rechazo cronico en un organo o un tejido transplantado | |
ATE518540T1 (de) | Beta-lactam verbindung enthaltende neurotherapeutische zusammensetzung | |
ATE173603T1 (de) | Behandlung von erektionversagen | |
ES2169128T3 (es) | Procedimientos para el tratamiento de enfermedades utilizando celulas de sertoli y aloinjertos o xenoinjertos. | |
EA200100376A1 (ru) | Арилсульфонанилидмочевины | |
BR9710737A (pt) | Pentafluorobenzenosulfonamidas e análogos. | |
EA200101089A1 (ru) | Новый способ лечения | |
ES2143132T3 (es) | Monohidratos de derivado de acido aminobenceno-sulfonico y su metodo de preparacion. | |
DE69935720D1 (de) | Diamino-propanol-verbindungen zur behandlung von ischaemien | |
SE0001914L (sv) | Förbättring av Peyronies sjukdom | |
GT199900015A (es) | Procedimiento para tratar la insuficiencia cardiaca | |
ES2174921T3 (es) | Inhibidores de la proteasa del vih. | |
GT199800135A (es) | 2 - aminopiridinas con sustituyentes alcoxi ramificados. | |
ES511604A0 (es) | "un procedimiento para la obtencion de un principio activo fibrinolitico vasal o vascular, quimicamente denominable "enzima angioquinasa"". | |
ES2187646T3 (es) | Procedimientos para el tratamiento de inflamaciones y composiciones correspondientes. | |
MY118986A (en) | Use of (alpha)-1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 456724 Country of ref document: ES |